News Financial Interview with ElsleyInterview today with Elsley.
The interview covers a number of areas.
To me what's most exciting is the pending NASDAQ listing, what's most disappointing is the update on Cortalex sales and how they will do a marketing ramp up later this year. Really the product has been for sale now for 5+ months and you will focus on it later this year, that's like a 12 month ramp up, very disappointing for current shareholders.
To me it's reads that they are so focused on Covid and AM trials that Cortalex is almost an afterthought.
Still, I'm long on CRDL, they will be a Billion Dollar company, so I see their shares trading between $30-50 within the next year.
Enjoy the read....
https://news.financial/interviews/interview-with-cardiol-therapeutics-how-the-heart-disease-specialist-company-plans-to-take-off-on-the-nasdaq-in-2021